vs

Side-by-side financial comparison of CHEMED CORP (CHE) and FactSet (FDS). Click either name above to swap in a different company.

FactSet is the larger business by last-quarter revenue ($607.6M vs $420.0M, roughly 1.4× CHEMED CORP). FactSet runs the higher net margin — 25.1% vs 15.8%, a 9.3% gap on every dollar of revenue. On growth, FactSet posted the faster year-over-year revenue change (6.9% vs 3.1%). Over the past eight quarters, CHEMED CORP's revenue compounded faster (5.9% CAGR vs 5.5%).

LG Chem Ltd., often referred to as LG Chemical, is the largest Korean chemical company and is headquartered in Seoul, South Korea. It was the 9th largest chemical company in the world by sales in 2021. It was first established as the Lucky Chemical Industrial Corporation, which manufactured cosmetics. It is now solely a business-to-business company.

FactSet Research Systems Inc., trading as FactSet, is an American financial data and software company headquartered in Norwalk, Connecticut, United States. The company provides integrated data and software. For fiscal year 2024, FactSet's total ASV and professional services revenues were $2.2 billion. FactSet's total market value is approximately $17 billion.

CHE vs FDS — Head-to-Head

Bigger by revenue
FDS
FDS
1.4× larger
FDS
$607.6M
$420.0M
CHE
Growing faster (revenue YoY)
FDS
FDS
+3.8% gap
FDS
6.9%
3.1%
CHE
Higher net margin
FDS
FDS
9.3% more per $
FDS
25.1%
15.8%
CHE
Faster 2-yr revenue CAGR
CHE
CHE
Annualised
CHE
5.9%
5.5%
FDS

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CHE
CHE
FDS
FDS
Revenue
$420.0M
$607.6M
Net Profit
$66.3M
$152.6M
Gross Margin
52.6%
Operating Margin
20.1%
31.6%
Net Margin
15.8%
25.1%
Revenue YoY
3.1%
6.9%
Net Profit YoY
1.7%
EPS (diluted)
$4.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHE
CHE
FDS
FDS
Q1 26
$420.0M
Q4 25
$639.3M
$607.6M
Q3 25
$624.9M
$596.9M
Q2 25
$618.8M
$585.5M
Q1 25
$646.9M
$570.7M
Q4 24
$411.0M
$568.7M
Q3 24
$391.4M
$562.2M
Q2 24
$374.6M
$552.7M
Net Profit
CHE
CHE
FDS
FDS
Q1 26
$66.3M
Q4 25
$76.8M
$152.6M
Q3 25
$64.2M
$153.6M
Q2 25
$52.5M
$148.5M
Q1 25
$71.8M
$144.9M
Q4 24
$90.3M
$150.0M
Q3 24
$75.8M
$89.5M
Q2 24
$70.9M
$158.1M
Gross Margin
CHE
CHE
FDS
FDS
Q1 26
Q4 25
35.2%
52.6%
Q3 25
31.5%
51.6%
Q2 25
29.8%
52.1%
Q1 25
33.5%
52.8%
Q4 24
1.2%
54.5%
Q3 24
-1.2%
54.1%
Q2 24
-4.1%
55.3%
Operating Margin
CHE
CHE
FDS
FDS
Q1 26
20.1%
Q4 25
15.7%
31.6%
Q3 25
12.0%
29.7%
Q2 25
11.0%
33.2%
Q1 25
14.6%
32.5%
Q4 24
27.7%
33.6%
Q3 24
23.5%
22.7%
Q2 24
23.5%
36.6%
Net Margin
CHE
CHE
FDS
FDS
Q1 26
15.8%
Q4 25
12.0%
25.1%
Q3 25
10.3%
25.7%
Q2 25
8.5%
25.4%
Q1 25
11.1%
25.4%
Q4 24
22.0%
26.4%
Q3 24
19.4%
15.9%
Q2 24
18.9%
28.6%
EPS (diluted)
CHE
CHE
FDS
FDS
Q1 26
Q4 25
$5.45
$4.06
Q3 25
$4.46
$4.03
Q2 25
$3.57
$3.87
Q1 25
$4.86
$3.76
Q4 24
$6.00
$3.89
Q3 24
$5.00
$2.33
Q2 24
$4.65
$4.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHE
CHE
FDS
FDS
Cash + ST InvestmentsLiquidity on hand
$16.9M
$292.7M
Total DebtLower is stronger
$91.2M
$1.4B
Stockholders' EquityBook value
$848.0M
$2.2B
Total Assets
$1.5B
$4.2B
Debt / EquityLower = less leverage
0.11×
0.63×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHE
CHE
FDS
FDS
Q1 26
$16.9M
Q4 25
$74.5M
$292.7M
Q3 25
$129.8M
$355.1M
Q2 25
$249.9M
$364.0M
Q1 25
$173.9M
$287.0M
Q4 24
$178.3M
$358.8M
Q3 24
$238.5M
$492.6M
Q2 24
$222.9M
$522.0M
Total Debt
CHE
CHE
FDS
FDS
Q1 26
$91.2M
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
$1.5B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.4B
Stockholders' Equity
CHE
CHE
FDS
FDS
Q1 26
$848.0M
Q4 25
$979.4M
$2.2B
Q3 25
$1.1B
$2.2B
Q2 25
$1.2B
$2.2B
Q1 25
$1.2B
$2.1B
Q4 24
$1.1B
$2.0B
Q3 24
$1.2B
$1.9B
Q2 24
$1.2B
$1.9B
Total Assets
CHE
CHE
FDS
FDS
Q1 26
$1.5B
Q4 25
$1.5B
$4.2B
Q3 25
$1.6B
$4.3B
Q2 25
$1.7B
$4.3B
Q1 25
$1.7B
$4.2B
Q4 24
$1.7B
$4.0B
Q3 24
$1.8B
$4.1B
Q2 24
$1.7B
$4.0B
Debt / Equity
CHE
CHE
FDS
FDS
Q1 26
0.11×
Q4 25
0.63×
Q3 25
0.63×
Q2 25
0.66×
Q1 25
0.72×
Q4 24
0.68×
Q3 24
0.71×
Q2 24
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHE
CHE
FDS
FDS
Operating Cash FlowLast quarter
$88.2M
$121.3M
Free Cash FlowOCF − Capex
$90.4M
FCF MarginFCF / Revenue
14.9%
Capex IntensityCapex / Revenue
4.1%
5.1%
Cash ConversionOCF / Net Profit
1.33×
0.79×
TTM Free Cash FlowTrailing 4 quarters
$647.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHE
CHE
FDS
FDS
Q1 26
$88.2M
Q4 25
$133.5M
$121.3M
Q3 25
$83.4M
$212.1M
Q2 25
$138.6M
$253.8M
Q1 25
$32.7M
$174.0M
Q4 24
$164.9M
$86.4M
Q3 24
$90.5M
$163.2M
Q2 24
$77.5M
$238.2M
Free Cash Flow
CHE
CHE
FDS
FDS
Q1 26
Q4 25
$117.2M
$90.4M
Q3 25
$66.0M
$178.1M
Q2 25
$122.8M
$228.6M
Q1 25
$19.5M
$150.2M
Q4 24
$152.2M
$60.5M
Q3 24
$77.0M
$137.2M
Q2 24
$66.5M
$216.9M
FCF Margin
CHE
CHE
FDS
FDS
Q1 26
Q4 25
18.3%
14.9%
Q3 25
10.6%
29.8%
Q2 25
19.8%
39.0%
Q1 25
3.0%
26.3%
Q4 24
37.0%
10.6%
Q3 24
19.7%
24.4%
Q2 24
17.7%
39.2%
Capex Intensity
CHE
CHE
FDS
FDS
Q1 26
4.1%
Q4 25
2.6%
5.1%
Q3 25
2.8%
5.7%
Q2 25
2.6%
4.3%
Q1 25
2.1%
4.2%
Q4 24
3.1%
4.5%
Q3 24
3.5%
4.6%
Q2 24
3.0%
3.9%
Cash Conversion
CHE
CHE
FDS
FDS
Q1 26
1.33×
Q4 25
1.74×
0.79×
Q3 25
1.30×
1.38×
Q2 25
2.64×
1.71×
Q1 25
0.46×
1.20×
Q4 24
1.83×
0.58×
Q3 24
1.19×
1.82×
Q2 24
1.09×
1.51×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHE
CHE

Homecare$371.1M88%
Inpatient$35.9M9%
Other$13.0M3%

FDS
FDS

Americas Segment$399.7M66%
EMEA Segment$149.1M25%
Asia Pacific Segment$62.2M10%

Related Comparisons